DNAJC5 and malaria: RTS,S/AS01 (GSK, Rixensart, Belgium), referred to throughout as RTS,S, the first malaria vaccine to be recommended by the WHO, targets the circumsporozoite protein (CSP), a key protein expressed on the surface of sporozoites [4].